Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.45 |
| ▸ | MGLL | Q99685 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 5/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL969243 | 0.92 | CA2 (0.55) | CA2SMN1; SMN2CA9CA12CA1 | |
| SCHEMBL28459415 | 0.92 | CA2 (0.55) | CA2SMN1; SMN2CA9CA12CA1 | |
| SCHEMBL17704474 | 0.92 | MAOB (0.42) | CA2MGLLBCL2L1BAK1CA12 | |
| SCHEMBL11595972 | 0.88 | CA2 (0.56) | CA2SMN1; SMN2CA9CA12CA1 | |
| SCHEMBL14798577 | 0.84 | CA2 (0.39) | CA2MGLLSMN1; SMN2CA9BCL2L1 | |
| SCHEMBL14797979 | 0.84 | CA2 (0.36) | CA2SMN1; SMN2CA9BCL2L1BAK1 | |
| SCHEMBL31594518 | 0.84 | CA2 (0.53) | CA2SMN1; SMN2CA9BCL2L1BAK1 | |
| SCHEMBL9051659 | 0.83 | BCL2L1 (0.39) | CA2SMN1; SMN2CA9BCL2L1BAK1 | |
| SCHEMBL18878046 | 0.83 | NR1I2 (0.49) | CA2MGLLSMN1; SMN2CA9CA12 | |
| SCHEMBL10823807 | 0.82 | CA1 (0.43) | CA2CA9BCL2L1BAK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1007587-B1 | RHEOLOGY MODIFICATION OF ELASTOMERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-04-05 | — | — | EP | claimed |
| CN-107406379-B | Non-explosive bis-sulfonyl azides | 戴纳米特诺贝尔爆炸材料和系统工程有限公司 | 2020-10-16 | — | — | CN | disclosed |
| EP-3268352-B1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-10385016-B2 | Non explosive bis-sulfonyl azides | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385016-B2 | Non explosive bis-sulfonyl azides | ARSA, MSRB3, NES | CA2 1475/4885MGLL 3839/4885SMN1; SMN2 1193/4885 |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | ARSA, MSRB3, NES | CA2 1444/4885MGLL 3856/4885SMN1; SMN2 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.